Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 14.20
-0.15 (-1.05%)
Jan 22, 2026, 1:09 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 8.35 billion as of January 21, 2026. Its market cap has decreased by -16.27% in one year.
Market Cap
8.35B
Enterprise Value
3.51B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.20
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 8.35B, a decrease of -63.56%. That is a compound annual growth rate of -33.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 8.38B | -6.19% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.84B |
| TaiGen Biopharmaceuticals Holdings | 10.00B |
| PharmaEngine | 10.00B |
| Gongwin Biopharm Holdings | 9.55B |
| Adimmune | 8.35B |
| Mycenax Biotech | 7.15B |
| OBI Pharma | 6.65B |
| Savior Lifetec | 6.27B |